Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101
- 3 April 2014
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 50 (9) , 1665-1674
Abstract
No abstract availableKeywords
Funding Information
- KIKA
- Dutch Cancer Society (UVA2008-4265)
This publication has 35 references indexed in Scilit:
- BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemiaExperimental Hematology, 2011
- GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagyCell Death & Disease, 2010
- Pro-apoptotic protein BIM in apoptosis of glucocorticoid-sensitive and -resistant acute lymphoblastic leukemia CEM cellsMedical Oncology, 2010
- Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistanceJournal of Clinical Investigation, 2010
- A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trialThe Lancet, 2007
- Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistanceCancer Cell, 2006
- Inhibition of Glucocorticoid-induced Apoptosis by Targeting the Major Splice Variants of BIM mRNA with Small Interfering RNA and Short Hairpin RNAJournal of Biological Chemistry, 2004
- Induction of apoptosis and bcl-2 expression in acute lymphoblastic leukaemia and non-Hodgkin's lymphoma in childrenHaematologia, 2001
- Role of BCL‐2 and cell cycle regulatory proteins for corticosensitivity assessment in childhood acute lymphoblastic leukaemiaBritish Journal of Haematology, 2000
- BCL-2 Expression in Childhood Leukemia Versus Spontaneous Apoptosis, Drug Induced Apoptosis, and in vitro Drug Resistance1999